Skip to main navigation Skip to search Skip to main content

The value of adriamycin and of mid-cycle treatment in multidrug therapy of unfavorable histology non-Hodgkin's lymphoma

  • G. J. Johnson
  • , W. G. Costello
  • , M. M. Oken

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)No. 793
JournalProceedings of the American Association for Cancer Research
VolumeVol. 20
StatePublished - 1979

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this